186 related articles for article (PubMed ID: 23947769)
1. Tissue plasminogen activator (tPA) for ischemic stroke in patients aged ≥80 years.
Zhou C; Zhu L; Wu J; Fang S
Acta Neurol Scand; 2013 Sep; 128(3):e17-8. PubMed ID: 23947769
[No Abstract] [Full Text] [Related]
2. Should physicians give tPA to patients with acute ischemic stroke? Against: and just what is the emperor of stroke wearing?
Hoffman JR
West J Med; 2000 Sep; 173(3):149-50. PubMed ID: 10986160
[No Abstract] [Full Text] [Related]
3. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study].
Di Pasquale G
Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744
[No Abstract] [Full Text] [Related]
4. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.
Yepes M; Roussel BD; Ali C; Vivien D
Trends Neurosci; 2009 Jan; 32(1):48-55. PubMed ID: 18963068
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little.
Hoffman JR
Med J Aust; 2003 Oct; 179(7):333-4. PubMed ID: 14503891
[No Abstract] [Full Text] [Related]
6. Should physicians give tPA to patients with acute ischemic stroke? For: thrombolytics in stroke: whose risk is it anyway?
Robinson DJ
West J Med; 2000 Sep; 173(3):148-9. PubMed ID: 10986159
[No Abstract] [Full Text] [Related]
7. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.
Liu S; Feng X; Jin R; Li G
Expert Opin Drug Deliv; 2018 Feb; 15(2):173-184. PubMed ID: 28944694
[TBL] [Abstract][Full Text] [Related]
8. Door-to-needle times in acute ischemic stroke: how low can we go?
Smith EE; von Kummer R
Neurology; 2012 Jul; 79(4):296-7. PubMed ID: 22622861
[No Abstract] [Full Text] [Related]
9. [Treatment of acute ischemic apoplexy].
Andersen G; Krieger DW; Iversen HK
Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
[No Abstract] [Full Text] [Related]
10. Further randomized controlled trials of tPA within 3 hours are required-not!
Lyden PD
Stroke; 2001 Nov; 32(11):2709-10. PubMed ID: 11692041
[No Abstract] [Full Text] [Related]
11. Response to letter regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
Liao X; Wang Y; Wang Y
Stroke; 2014 Dec; 45(12):e304. PubMed ID: 25342031
[No Abstract] [Full Text] [Related]
12. Intravenous thrombolytic therapy for acute ischemic stroke.
Wechsler LR
N Engl J Med; 2011 Jun; 364(22):2138-46. PubMed ID: 21631326
[No Abstract] [Full Text] [Related]
13. Letter by Chao et al regarding article, "standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses".
Chao AC; Po HL; Chan L
Stroke; 2014 Dec; 45(12):e303. PubMed ID: 25342029
[No Abstract] [Full Text] [Related]
14. Treatment of acute ischemic stroke, Part 1.
Fullerton T
J Am Pharm Assoc (Wash); 1996 Oct; NS36(10):571-2. PubMed ID: 8908931
[No Abstract] [Full Text] [Related]
15. Tissue plasminogen activator for acute ischaemic stroke.
Fatovich DM
Med J Aust; 2008 Apr; 188(8):489; author reply 490. PubMed ID: 18429725
[No Abstract] [Full Text] [Related]
16. Initial body temperature in ischemic stroke: nonpotentiation of tissue-type plasminogen activator benefit and inverse association with severity.
Kim SH; Saver JL
Stroke; 2015 Jan; 46(1):132-6. PubMed ID: 25424482
[TBL] [Abstract][Full Text] [Related]
17. The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial.
Kamel H; Patel N; Rao VA; Cullen SP; Faigeles BS; Smith WS; Flint AC
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1111-6. PubMed ID: 23122722
[TBL] [Abstract][Full Text] [Related]
18. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
Schestatsky P; Picon PD
Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16344546
[No Abstract] [Full Text] [Related]
19. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
Zhang B; Sun XJ; Ju CH
Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
[TBL] [Abstract][Full Text] [Related]
20. Breaking up is hard to do: tenecteplase in acute stroke.
Schwamm LH
Lancet Neurol; 2015 Apr; 14(4):343-5. PubMed ID: 25726503
[No Abstract] [Full Text] [Related]
[Next] [New Search]
